Related Experiment Videos
DSS-induced colitis is exacerbated in STAT-6 knockout mice.
John W Elrod1, F Stephen Laroux, Jeffrey Houghton
1Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, 71130, USA.
Inflammatory Bowel Diseases
|September 29, 2005
Summary
Signal transducer and activator of transcription-6 (STAT-6) plays a key role in inflammatory bowel disease (IBD) pathogenesis. STAT-6 deficiency exacerbates DSS-induced colitis, suggesting a protective role in regulating inflammation.
Area of Science:
- Immunology
- Gastroenterology
- Molecular Biology
Background:
- Inflammatory bowel disease (IBD) is a group of chronic gastrointestinal disorders.
- Transcription factors, including signal transducer and activator of transcription-6 (STAT-6), are implicated in IBD regulation.
Purpose of the Study:
- To investigate the role of STAT-6 in the dextran sulfate sodium (DSS)-induced murine model of colitis.
- To determine if STAT-6 influences disease activity, colonic injury, and inflammatory markers in colitis.
Main Methods:
- Utilized a 5% DSS-induced murine model of colitis.
- Compared disease activity index (DAI), colonic histology, and serum/tissue inflammatory markers between STAT-6 knockout and wildtype mice.
Main Results:
- STAT-6 knockout mice exhibited significantly increased DAI and proximal colon injury compared to wildtype controls.
- Both STAT-6 knockout and wildtype mice showed severe inflammation and crypt damage.
- STAT-6 knockout mice displayed elevated serum nitrite/nitrate and tissue interferon-gamma levels.
Conclusions:
- STAT-6 appears to play a protective role in DSS-induced colitis, potentially by modulating inducible NO synthase (iNOS) and limiting nitric oxide (NO) formation.
- STAT-6 may be a critical regulator in inflammatory bowel disease pathogenesis, influencing inflammation through iNOS and interferon-gamma pathways.